Peter J. Pitts is President of the Center for Medicine in the Public Interest and a Visiting Professor at the University of Paris School of Medicine. He is a former Associate Commissioner of the US Food and Drug Administration and member of the United States Senior Executive Service.
Using Section 232 national-security tariffs on imported medical equipment risks repeating the same mistakes that have long plagued U.S. health policy: relying on blunt instruments for complex problems.
His longstanding anti-vaccine rhetoric and vocal opposition to science-backed expert consensus has caused widespread concern among public health and medical professionals about the appropriateness of his leadership.
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
How can physicians and patients be confident enough that vendors entirely ignorant of the FDA process for repair and reporting can properly recalibrate life-saving machines? Is this really the right place to argue that “anyone can do it?”
Policymakers should recognize the advantages of this multi-faceted care model and ensure legislative and regulatory environments allow for its continued growth.
Healthcare devices must be exempted from general right to repair legislation.